Neil Kumar

CIK 1742485 · Chief Executive Officer · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$306.06M

Companies

2

Total Filings

79

Lifetime Open-Market Net

-$73.07M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BBIO Chief Executive Officer 4,581,774 $66.80 $306.06M -$145.07M 76 2026-06-08
Eidos Therapeutics, Inc. (EIDX) Delisted Chief Executive Officer 24,575,501 $72.01M 3 2019-07-08

Recent Filings · Page 5 of 8

79 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-05-05 BBIO Sell (S) −120,000 -$1.70M EDGAR
2023-04-07 BBIO Sell (S) −120,000 -$1.86M EDGAR
2023-03-03 BBIO Sell (S) −120,000 -$1.32M EDGAR
2023-02-21 BBIO Mixed -$871.3K EDGAR
2023-02-14 BBIO Grant (A) $0 EDGAR
2023-02-06 BBIO Sell (S) −120,000 -$1.32M EDGAR
2023-01-06 BBIO Sell (S) −120,000 -$920.9K EDGAR
2022-12-21 BBIO Sell (S) −200,000 $0 EDGAR
2022-11-18 BBIO Mixed -$654.0K EDGAR
2022-08-18 BBIO Mixed +41,008 -$306.9K EDGAR
Showing 4150 of 79
Page 5 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.